Principal Financial Group Inc. Purchases New Shares in Astrana Health, Inc. (NASDAQ:ASTH)

Principal Financial Group Inc. acquired a new position in shares of Astrana Health, Inc. (NASDAQ:ASTH) during the 3rd quarter, Holdings Channel reports. The firm acquired 230,975 shares of the company’s stock, valued at approximately $13,383,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of ASTH. Central Pacific Bank Trust Division bought a new position in Astrana Health during the third quarter worth about $160,000. SG Americas Securities LLC acquired a new position in shares of Astrana Health during the 3rd quarter worth approximately $680,000. Granite Bay Wealth Management LLC bought a new position in shares of Astrana Health during the third quarter worth approximately $290,000. Handelsbanken Fonder AB acquired a new stake in shares of Astrana Health in the third quarter valued at approximately $492,000. Finally, GAMMA Investing LLC bought a new stake in shares of Astrana Health in the third quarter valued at approximately $34,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have commented on the company. BTIG Research raised their price objective on Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a research note on Thursday, October 3rd. Robert W. Baird boosted their price target on Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a research note on Wednesday, November 13th. KeyCorp started coverage on shares of Astrana Health in a research note on Friday, October 11th. They set a “sector weight” rating on the stock. TD Cowen initiated coverage on shares of Astrana Health in a research report on Monday, October 14th. They issued a “buy” rating and a $66.00 target price for the company. Finally, Macquarie upgraded shares of Astrana Health to a “hold” rating in a research report on Monday, December 16th. Two research analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, Astrana Health presently has a consensus rating of “Moderate Buy” and an average price target of $65.17.

Astrana Health Trading Down 2.4 %

ASTH opened at $32.72 on Friday. The company’s 50 day moving average is $44.45 and its 200-day moving average is $47.57. The company has a market cap of $1.84 billion, a P/E ratio of 25.17, a PEG ratio of 1.80 and a beta of 1.13. Astrana Health, Inc. has a 1-year low of $32.21 and a 1-year high of $63.20. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.33 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.33. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The company had revenue of $478.71 million during the quarter, compared to the consensus estimate of $462.01 million. During the same period in the prior year, the business earned $0.47 earnings per share. Equities research analysts predict that Astrana Health, Inc. will post 1.16 earnings per share for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.